Business

Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration

Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration

articleJointown Pharmaceutical Group Co., Ltd. Class ADecember 17, 20254/news/indicative-announcement-completion-of-the-redemption-and-delisting-of-the-2022-non-convertible-corporate-bonds-phase-ii-by-the-controlling-shareholder-and-the-intention-to-handle-the-release-of-stock-pledge-and-trust-registration
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration

About this update from Jointown Pharmaceutical Group Co., Ltd. Class A

Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jointown Pharmaceutical Group Co., Ltd. Class A